期刊文献+

ROCK对系统性红斑狼疮患者外周血T细胞黏附和迁移的调控 被引量:4

Abnormal activity of ROCK contributes to increased adhesion and migration of peripheral blood T cells from patients with systemic lupus erythematosus
暂未订购
导出
摘要 目的:研究系统性红斑狼疮(SLE)患者外周血T细胞中Rho激酶(ROCK)活化情况,并探讨其对T细胞黏附和迁移的影响。方法:收集SLE患者33例,正常健康人12例和类风湿关节炎患者9例作为对照组。外周血T细胞分离采用RosettSep T细胞提取试剂盒提取,ROCK活性用磷酸化肌球蛋白磷酸酶靶亚基1(MYPT1)蛋白表达来表示,磷酸化MYPT1蛋白检测采用免疫印迹法,T细胞迁移采用Transwell小室测定。结果:新鲜分离的SLE患者外周血T细胞ROCK活性均显著高于正常对照组和类风湿关节炎组(均P<0.05)。SLE患者T细胞体外黏附和迁移能力显著高于正常对照组;ROCK特异性抑制剂Y27632显著抑制SLE患者T细胞黏附和迁移。结论:SLE患者存在T细胞ROCK活化异常;ROCK可能参与调控SLE T细胞的黏附和迁移;抑制T细胞异常的ROCK活性可能有助于SLE的治疗。 AIM: To investigate the role of Rho kinase (ROCK) in the regulation of adhesion and migration of the T cells from systemic lupus erythematosus (SLE) patients. METHODS: The T cells were isolated by RosettSep T cell purification kit. ROCK activity was assessed by Western blotting. T cell migration was examined by Transwell chambers. RESULTS : Compared with the T cells from healthy controls and rheumatoid arthritis patients, the activity of ROCK in ex vivo T cells from SLE patients was significantly increased. In vitro, the adhesion and migration of the T cells from SLE pa- tients were also increased. Furthermore, the adhesion and migration of the T cells from SLE patients were inhibited by a specific ROCK inhibitor Y27632. CONCLUSION: The results indicate that ex vivo T cells from SLE patients exhibit in- creased activity of ROCK. Alteration of ROCK activity may contribute to the abnormal adhesion and migration of T cells from SLE patients.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2012年第12期2270-2273,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30671951) 教育部出国留学回国人员启动基金资助项目(No.教外司2006-331) 广东省科技计划基金资助项目(No.2008B080703015 No.2011B080701011)
关键词 红斑狼疮 系统性 T淋巴细胞 RHO激酶 Lupus erythematosus, systemic T - lymphoeytes Rho kinase
  • 相关文献

参考文献10

  • 1Horowitz DA, Stohl W, Gray JD. T lymphocytes, natural killer cells and immune regulation [ M]//Wallanee DJ, Hahn BH. Dubois' lupus erythematosus. 6th edition. Philadelphia: Lippincott, Williams & Wilkins, 2002 : 157 - 185.
  • 2梁柳琴,许韩师,叶玉津,詹钟平,杨岫岩.白细胞介素-15在狼疮性肾炎活动病变中的临床意义[J].中国病理生理杂志,2008,24(8):1581-1584. 被引量:6
  • 3Burridge K, Wennerberg K. Rho and Rae take center stage[J]. Cell, 2004, 116(2) :167 -179.
  • 4Street CA, Bryan BA. Rho kinase proteins: pleiotropic modulators of cell survival and apoptosis [ J ]. Anticancer Res, 2011,31 ( 11 ) :3645 - 3657.
  • 5Estess P, DeGrendele HC, Pascual V, et al. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity [ J ]. J Clin Invest, 1998, 102(6) : 1173 - 1182.
  • 6Li Y, Harada T, Juang YT, et al. Phosphorylated ERM is responsible for increased T cell polarization, adhesion and migration in patients with systemic lupus erythematosus [J]. J Immunol, 2007, 178(3) :1938 - 1947.
  • 7Delprato A. Topological and functional properties of the small GTPases protein interaction network[ J]. PLoS One, 2012,7(9) : e44882.
  • 8Honing H, van den Berg TK, van der Pol SM, et al. RhoA activation promotes transendothelial migration of monocytes via ROCK[J]. J Leukoc Biol, 2004, 75(3) : 523 - 528.
  • 9Worthylake RA, Burridge K. RhoA and ROCK promotes migration by limiting membrane protrusions [ J ]. J Biol Chem, 2003, 278 (15) : 13578 - 13584.
  • 10Noma K, Rikitake Y, Oyama N, et al. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury[J]. J Clin Invest, 2008, 118(5) : 1632 - 1644.

二级参考文献14

  • 1王东勇,黄建生,郭明秋.白介素15[J].生命的化学,1996,16(3):26-28. 被引量:7
  • 2唐可京,李幼姬,谢灿茂,祝胜郎,陈文芳,余学清.Fractalkine/CX3CR1在Ⅳ型狼疮肾炎患者肾组织中的表达[J].中国病理生理杂志,2007,23(5):908-912. 被引量:7
  • 3董怡 见:叶任高 陆再英 主编.系统性红斑狼疮[A].见:叶任高,陆再英,主编.内科学[M]:第6版[C].北京:人民卫生出版社,2004.892-898.
  • 4许韩师,张道友.系统性红斑狼疮细胞因子的产生异常[A].见:叶任高,张道友,刘冠贤主编.红斑狼疮[M].第1版.北京:人民卫生出版社,2003.31-35.
  • 5Bombardies C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients[J]. Arthritis Rheum, 1992,35(6) :630-640.
  • 6Fehniger TA, Caligiuri MA. Interleukin 15:biology and relevance to human disease[J]. Blood, 2001, 97( 1 ) :14 -27.
  • 7Baranda L, de la Fuente H, Layseca - Espinosa E, et al. IL - 15 and IL - ISR in leucocytes from patients with systemic lupus erythematosus [J]. Rheumatology ( Oxford ), 2005, 44(12) :1507 - 1513.
  • 8Musso T, Calosso L, Zucca M, et al. Human monocytes constitutively express membrane - bound, biologically active, and interferon- gamma- upregulated interleukin- 15[J]. Blood, 1999, 93(10) : 3531 -3539.
  • 9Girard D, Paquet ME, Paquin R, et al. Differential effects of interleukin - 15 ( IL - 15 ) and IL - 2 on human neutrophils : modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL - 15 [J]. Blood, 1996, 88(8): 3176-3184.
  • 10Aringer M, Stummvoll GH, Steiner G, et al. Serum interleukin- 15 is elevated in systemic lupus erythematosus [J]. Rheumatology (Oxford), 2001, 40(8): 876- 881.

共引文献5

同被引文献77

  • 1余月明.系统性红斑狼疮肝脏损害83例临床观察[J].重庆医学,2004,33(9):1394-1395. 被引量:16
  • 2Runyon BA,LaBrecque DR,Anuras S. The spectrum of liver disease in systemic lupus erythematosus:report of 33 histologically-proved cases and review of the literature[J].American Journal of Medicine,1980,(02):187-194.
  • 3Zhu Y,Li F,Guo GL. Tissue-specific function of farnesoid X receptor in liver and intestine[J].Pharmacological Research,2011,(04):259-265.
  • 4Zhang Y,Yin L,Anderson J. Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia[J].Journal of Biological Chemistry,2010,(05):3035-3043.
  • 5Mencarelli A,Renga B,Migliorati M. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis[J].Journal of Immunology,2009,(10):6657-6666.
  • 6Xing X,Burgermeister E,Geisler F. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy[J].Hepatology,2009,(03):979-988.
  • 7Lian F,Xing X,Yuan G. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage[J].Biochemical Journal,2011,(02):315-323.
  • 8Takahashi A,Abe K,Yokokawa J. Clinical features of liver dysfunction in collagen diseases[J].Hepatology Research,2010,(11):1092-1097.
  • 9Kim I,Morimura K,Shah Y. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice[J].Carcinogenesis,2007,(05):940-946.
  • 10Yang F,Huang X,Yi T. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor[J].Cancer Research,2007,(03):863-867.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部